Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
St. Petersburg State Pavlov Medical University
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Marek Cezary Chawarski, Yale University
ClinicalTrials.gov Identifier:
NCT01389167
First received: July 5, 2011
Last updated: November 5, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)